Ring finger protein, transmembrane 1 pseudogene 3 (RNFT1P3)

RNFT1P3 refers to a pseudogene homologous to "Ring finger protein, transmembrane 1" (RNFT1), which is known as a E3 ubiquitin ligase possessing a RING finger domain relevant to protein ubiquitination and degradation processes[1][5]. However, unlike its protein-coding parent, RNFT1P3 is classified as a **pseudogene**, meaning it is a genomic sequence similar to a known gene (RNFT1) but is generally regarded as non-functional in terms of protein coding[3]. Pseudogenes like RNFT1P3 may be transcribed into RNA, occasionally exerting *regulatory effects* such as acting as decoys for microRNAs, modulating the expression of protein-coding genes, or participating in RNA interference pathways[2][4]. There are no described roles of RNFT1P3 in direct disease mechanisms, clinical utility, or as a mediator of drug action. As such, it is not considered a valid target for pharmaceutical development, nor is there evidence of biomarker utility or safety concerns due to therapeutic manipulation. Its classification reflects a pseudogene with possible noncoding RNA-based regulatory functionality but no known protein-level activity[2][3][4]. If requiring a canonical drug target entry, RNFT1P3 should be flagged as non-target with the above caveats.

Other names

RNFT1 Pseudogene 3